Acute myeloid leukemia (AML) progresses more rapidly than other forms of leukemia. As such, if you or your patient are concerned they may have AML it is important to educate them on the symptoms and risk factors of the disease, as well as how to detect it and what treatments it could entail.
Patients who have undergone either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) are at high risk for mortality in the event of a COVID-19 diagnosis.
Researchers are exploring the potential immunomodulatory and anti-inflammatory effects of UC-MSC infusions for ARDS in COVID-19.
Six months after hematopoietic stem cell transplantation, nearly 20% of enrolled patients had experienced clinically significant PTSD symptoms.
The FDA has sent an untitled letter to R3 Stem Cell, LLC of Scottsdale, Arizona for marketing unapproved stem cell products to treat a variety of diseases and conditions.
Patients who developed cerebrovascular disease following allogeneic hematopoietic stem cell transplantation experienced decreased survival.
Early vaccination of autologous hemopoietic stem-cell transplant (auto-HSCT) recipients during the peri-transplant period can be effective for the prevention of infections such as herpes zoster.
In a phase 3 clinical trial, early vaccination effectively prevented herpes zoster in auto-HSCT recipients.
